Bangalore (Karnataka) [India], October 18: Bionova, the renowned Bangalore-based pharmaceutical company, is making waves with the launch of its latest product, Commando Balm, marking its entry into the thriving analgesic market. With a mission to provide effective, herbal-based pain relief solutions, Bionova aims to set a new benchmark in the industry. Managing Director Suddhir Jain believes that Commando Balm will be a game-changer, thanks to its unique formulation and natural ingredients.
The global analgesics market, valued at USD 30 billion in 2023, continues to grow steadily, with the Indian market alone worth over INR 7,000 crores. The increasing consumer demand for herbal alternatives in pain relief, driven by the desire for fewer side effects and safer options, is reshaping the industry. In India, herbal products now account for nearly 20% of the analgesic market, a trend set to grow in the coming years.
Commando Balm is positioned to compete with industry giants like Emami’s Zandu Balm, Amrutanjan, and Moov, all of which have a long-standing reputation for providing reliable pain relief. However, Bionova’s herbal formulation offers a fresh, natural alternative, catering to the rising consumer preference for clean, chemical-free products.
“We formulated Commando Balm with powerful natural ingredients, aiming to provide relief from common issues such as headaches, muscle pain, and joint discomfort,” said Suddhir Jain. “As consumers increasingly lean towards herbal products that are both effective and safe, Commando Balm is our response to this growing demand.”
Industry experts agree that the shift towards natural and sustainable products is transforming not just the analgesic sector but the pharmaceutical and healthcare industries as a whole. Companies like Bionova, with their focus on herbal solutions, are uniquely positioned to take advantage of this shift.
As Commando Balm prepares to hit shelves nationwide, Bionova is primed to expand its presence in the pharmaceutical market. This product launch reinforces the company’s commitment to innovation, consumer wellness, and long-term growth.
For media inquiries, please contact:
Pragati Biocare Pvt Ltd
Email: [email protected]
Phone: (+91)9900007723
Website: www.bionova.co.in
If you have any objection to this press release content, kindly contact [email protected] to notify us. We will respond and rectify the situation in the next 24 hours.
